86 related articles for article (PubMed ID: 11396241)
1. Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma.
Lee JK; Tsai SC; Ho YJ; Changlai SP; Kao CH
Anticancer Res; 2001; 21(2B):1509-13. PubMed ID: 11396241
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of technetium-99m tetrofosmin scan to detect non-Hodgkin's lymphoma.
Liu FY; Shiau YC; Kao A; Liang JA; Yang SN
Anticancer Res; 2003; 23(3C):2951-3. PubMed ID: 12926142
[TBL] [Abstract][Full Text] [Related]
3. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
4. Using technetium-99m-tetrofosmin scan to predict chemotherapy response of malignant lymphomas, compared with P-glycoprotein and multidrug resistance related protein expression.
Liang JA; Shiau YC; Yang SN; Lin FJ; Lin CC; Kao A; Lee CC
Oncol Rep; 2002; 9(2):307-12. PubMed ID: 11836597
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-tetrofosmin scintigraphy in the prediction of chemotherapy response of untreated malignant lymphomas and comparison with other prognostic factors.
Sun SS; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Anticancer Res; 2001; 21(1B):685-8. PubMed ID: 11299826
[TBL] [Abstract][Full Text] [Related]
6. Predicting chemotherapy response and comparing with P-glycoprotein expression using technetium-99m tetrofosmin scan in untreated malignant lymphomas.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Lett; 2001 Sep; 170(2):139-46. PubMed ID: 11463491
[TBL] [Abstract][Full Text] [Related]
7. The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter.
Karayalçin U; Ciftçi F; Boz A; Boz S; Karayalçin B
Ann Nucl Med; 1997 Nov; 11(4):285-90. PubMed ID: 9460519
[TBL] [Abstract][Full Text] [Related]
8. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Fattori B; Grosso M; Nacci A; Bianchi F; Cosottini M; Ursino F; Manca G; Rubello D; Strauss HW; Mariani G
Cancer Biother Radiopharm; 2005 Feb; 20(1):27-35. PubMed ID: 15778576
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
[TBL] [Abstract][Full Text] [Related]
10. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gallium-67 citrate and technetium-99m tetrofosmin scan to detect Hodgkin's disease.
Liu FY; Shiau YC; Yen RF; Wang JJ; Ho ST; Kao CH
Ann Nucl Med; 2003 Sep; 17(6):439-42. PubMed ID: 14575376
[TBL] [Abstract][Full Text] [Related]
13. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
[TBL] [Abstract][Full Text] [Related]
14. Tetrofosmin as predictors of tumour response.
Fuster D; Viñolas N; Mallafré C; Pavia J; Martín F; Pons F
Q J Nucl Med; 2003 Mar; 47(1):58-62. PubMed ID: 12714956
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of chemotherapy response using technetium-99M-sestamibi scintigraphy in untreated adult malignant lymphomas and comparison with other prognosis factors: a preliminary report.
Kao CH; Tsai SC; Wang JJ; Ho YJ; Ho ST; Changlai SP
Int J Cancer; 2001 Jul; 95(4):228-31. PubMed ID: 11400115
[TBL] [Abstract][Full Text] [Related]
17. [Detection of melanoma metastases with Tc-99m-tetrofosmin].
Rettenbacher L; Koller J; Kässmann H; Galvan G
Nuklearmedizin; 2000; 39(4):97-101. PubMed ID: 10919159
[TBL] [Abstract][Full Text] [Related]
18. Detection of cervical lymph node metastases of nasopharyngeal carcinomas with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Anticancer Res; 2001; 21(1B):723-6. PubMed ID: 11299833
[TBL] [Abstract][Full Text] [Related]
19. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
Gallowitsch HJ; Kresnik E; Mikosch P; Pipam W; Gomez I; Lind P
Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m tetrofosmin imaging in malignant lymphomas.
Schillaci O; Filippis AM; Anselmo AP; Monteleone F; Capoccetti F; Massa R; Maurizi Enrici R; Scopinaro F
Tumori; 2002; 88(3):S24-5. PubMed ID: 12365376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]